Physician

Eleonora G Lad, MD, PHD

According to 2025 Medicare claims, Eleonora Lad, MD, PHD (NPI: 1811150576) practices ophthalmology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27560-5676. Lad is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Lad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 424 traditional Medicare patients, billed 23,737 HCPCS/CPT codes, and received $1,814,539 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 87 prescription claims across 45 beneficiaries totaling $10,310 in drug costs, led by Ketorolac Tromethamine (Ketorolac Tromethamine). Open Payments data shows 64 records totaling $999,355. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $453,307 to $1,814,539. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,104 and ending at $10,310. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$907K$1.8M2015 Medicare payment: $453,307 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $750,149 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,058,382 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,285,460 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,376,947 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,264,515 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,331,662 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,308,060 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,437,076 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,814,539 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152162,053$453,307
20162402,909$750,149
20172693,809$1,058,382
20182724,394$1,285,460
20193344,977$1,376,947
20203344,408$1,264,515
20213904,843$1,331,662
20224278,094$1,308,060
202342921,875$1,437,076
202442423,737$1,814,539

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$10K$21K2015 Drug cost: $4,104 (USD; Tot_Drug_Cst)2016 Drug cost: $3,044 (USD; Tot_Drug_Cst)2017 Drug cost: $8,690 (USD; Tot_Drug_Cst)2018 Drug cost: $16,461 (USD; Tot_Drug_Cst)2019 Drug cost: $13,383 (USD; Tot_Drug_Cst)2020 Drug cost: $16,586 (USD; Tot_Drug_Cst)2021 Drug cost: $20,921 (USD; Tot_Drug_Cst)2022 Drug cost: $6,724 (USD; Tot_Drug_Cst)2023 Drug cost: $10,266 (USD; Tot_Drug_Cst)2024 Drug cost: $10,310 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151325$4,104
20161747$3,044
201733109$8,690
201841132$16,461
20194195$13,383
202040122$16,586
202142102$20,921
202257150$6,724
20234297$10,266
20244587$10,310

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye147803$93
92014Established patient complete exam of visual system407800$85
92134Imaging of retina244719$28
92250Photography of the retina216271$25
92201Extended exam of the back part of the eye with retinal drawing166250$18

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Ketorolac TromethamineKetorolac Tromethamine12326$403
ErythromycinErythromycin Base25184$324

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.44$98,274Boehringer Ingelheim International GmbH
Research PaymentsReported research-related payment or transfer-of-value amount.20$901,082Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Eleonora G. Lad, MD, PHD?

Tedicare shows public-source Medicare data for Eleonora G. Lad, MD, PHD (NPI 1811150576), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eleonora G. Lad, MD, PHD have ACO affiliation data?

Eleonora G. Lad, MD, PHD is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Eleonora G. Lad, MD, PHD?

Eleonora G. Lad, MD, PHD is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Eleonora G. Lad, MD, PHD have Open Payments data?

Eleonora G. Lad, MD, PHD has 64 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.